HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France
Infection 2024

Rakesh Kumar Deepak

Speaker at Infection Conference - Rakesh Kumar Deepak
All India Institute of Medical Sciences, India
Title : Atypical cytokine profile in early SARS-CoV-2 infection may indicate progression from mild to moderate disease: Possible role for IL-22


The coronavirus pandemic is still a major public health problem worldwide. It was started in Wuhan (a city in China), and the individuals started reporting the clinical manifestations were fever (moderate to high), dry cough, body aches, diarrhea, and headache. Usually, disease manifestation is mild to moderate with 6-8 weeks of recovery. Mild disease may be accompanied by dyspnea and hypoxia with/without radiological evidence in the lungs. Moderate cases usually have dyspnea with hypoxia and usually show an altered cytokine pattern. Severe cases of Covid-19 exhibit acute respiratory distress syndrome (ARDS), septic shock, and cytokine storm which may lead to multiple organ failures and eventually death. Therefore, we undertook this case-control study to determine the immunopathogenesis of COVID-19. The study aimed to determine T cell subtypes and cytokines in COVID-19 patients with mild to severe disease and compare them between patients who had recovered and those who had progressed to moderate to severe disease.


Dr. Rakesh Kumar Deepak studied Medicine at the B.R.D. Medical College, India and graduated as MBBS in 2008. He then studied Pathology at AIIMS, New Delhi and received his MD degree in 2013. After three years of being senior resident at AIIMS, New Delhi, he obtained Associate Professor position at Department of Transplant Immunology and Immunogenetics at the same Institute. He has a US patent on ‘Device, system and method for real time monitoring and analysis of health parameters relating to non-communicable diseases’ and has published more than 15 research articles in SCI(E) journals.)